SCHEMBL20565352

SCHEMBL20565352

CC(C)OC(=O)C(C(=O)OC(C)C)N(c1ccccc1)C1CCCC1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.40
MEN1 O00255 1/20 0.40
NPC1 O15118 1/20 0.40
MITF O75030 1/20 0.40
ALDH1A1 P00352 1/20 0.40
RAB9A P51151 1/20 0.40
KMT2A Q03164 1/20 0.40
PAX8 Q06710 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
TRPM8 Q7Z2W7 3/20 0.38
ATM Q13315 1/20 0.38
PKM P14618 1/20 0.38
POLB P06746 1/20 0.37
LMNA P02545 2/20 0.36
CYP1A2 P05177 2/20 0.36
CYP2D6 P10635 2/20 0.36
SCN1A P35498 1/20 0.36
SCN2A Q99250 1/20 0.36
SCN3A Q9NY46 1/20 0.36
TSHR P16473 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25439978 0.99 MEN1 (0.43) KDM4EMEN1NPC1MITFALDH1A1
SCHEMBL20564728 0.94 TSHR (0.38) SMN1; SMN2TRPM8LMNATSHRCHRM2
SCHEMBL20564575 0.87 POLB (0.39) NPC1ALDH1A1RAB9ASMN1; SMN2TRPM8
SCHEMBL26324928 0.86 KDM4E (0.39) KDM4EMEN1NPC1MITFALDH1A1
SCHEMBL26324931 0.85 KDM4E (0.41) KDM4EMEN1NPC1MITFALDH1A1
SCHEMBL26327751 0.81 CHRM2 (0.43) KDM4EMEN1NPC1MITFALDH1A1
SCHEMBL26324875 0.80 TRPM8 (0.36) SMN1; SMN2TRPM8LMNATSHRCHRM2
SCHEMBL20564030 0.80 GPR119 (0.52) KDM4EMEN1NPC1ALDH1A1RAB9A
SCHEMBL26327769 0.80 CHRM2 (0.44) KDM4EMEN1NPC1MITFALDH1A1
SCHEMBL20565056 0.78 ALDH1A1 (0.33) MEN1ALDH1A1KMT2ATRPM8PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11767291-B2 Preparation of secondary amines with electrophilic N-linchpin reagents WILLIAM MARSH RICE UNIVERSITY (US) 2023-09-26 US disclosed
WO-2018213572-A9 PREPARATION OF SECONDARY AMINES WITH ELECTROPHILIC N-LINCHPIN REAGENTS WILLIAM MARSH RICE UNIVERSITY (US) 2018-12-13 WO disclosed
WO-2018213572-A1 PREPARATION OF SECONDARY AMINES WITH ELECTROPHILIC N-LINCHPIN REAGENTS WILLIAM MARSH RICE UNIVERSITY (US) 2018-11-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11767291-B2 Preparation of secondary amines with electrophilic N-linchpin reagents PNMT, NCL, NPM1 KDM4E 1342/4885MEN1 296/4885NPC1 2535/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.